Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
Authors:
- 16 February 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 4 (5) , 788-796
Abstract
Antigen multimerization on a nanoparticle can result in improved neutralizing antibody responses. A platform that has been successfully used for displaying antigens from a number of different viruses is ferritin, a self-assembling protein nanoparticle that allows the attachment of multiple copies (twenty-four monomers or eight trimers) of a single antigen. Here we design two-component ferritin variants that allow the attachment of two diverse antigens on a single particle in a defined ratio and geometric pattern. The two-component ferritin was specifically designed for trimeric antigens, accepting four trimers per particle for each antigen, and was tested with antigens derived from HIV-1 envelope (Env) and influenza hemagglutinin (HA). Particle formation and the presence of native-like antigen conformation were confirmed through negative-stain electron microscopy and antibody-antigen binding analysis. Immunizations in guinea pigs with two-component ferritin particles displaying diverse Env, HA, or both antigens, elicited neutralizing antibody responses against the respective viruses. The results provide proof-of-principle for self-assembly of a two-component nanoparticle as a general technology for multimeric immunogen presentation of trimeric antigens.Keywords
Funding Information
- Division of Intramural Research (ZIA AI005024-16)
- U.S. Department of Health and Human Services (HHSN261200800001E)
This publication has 36 references indexed in Scilit:
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing AntibodiesPLOS Pathogens, 2013
- Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral StrainsJournal of Virology, 2013
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Nature, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in ChinaJournal of Biological Chemistry, 2011
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing AntibodiesJournal of Virology, 2010
- A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsVaccine, 2009
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2007
- Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway EpitheliumJournal of Virology, 2006